BusinessETST and its wholly owned subsidiary, Cannabis Therapeutics, Signs Joint Venture with Smart Medicines GMP for the Development of its Cannabis Cannabinoid-Based Drugs & NutraceuticalsBy Nasdaq OMXFeb 14, 2017, 12:15 PM UTC
BusinessAXIM Biotech to Attend the 19th Annual BIO CEO & Investor Conference in New YorkBy Nasdaq OMXFeb 9, 2017, 2:02 PM UTC
BusinessAXIM Biotech to Attend the 19th Annual BIO CEO & Investor Conference in New YorkBy Nasdaq OMXFeb 9, 2017, 2:02 PM UTC
BusinessAXIM Biotech to Attend the 19th Annual BIO CEO & Investor Conference in New YorkBy Nasdaq OMXFeb 9, 2017, 2:02 PM UTC
BusinessEarth Science Tech Strengthens Advisory Board with Four Distinguished Scientists and Doctors to Expand the Pharmaceutical & Nutraceutical Development of Cannabinoids' Therapeutic Indications, R&D, Technology, IP and TreatmentsBy Nasdaq OMXFeb 9, 2017, 12:45 PM UTC
BusinessEarth Science Tech Announces New Wholly Owned Subsidiary, Cannabis Therapeutics Inc., to Develop & Launch its Cannabis Cannabinoid-Based Drugs & Nutraceuticals Using its Cannabinoid-Cannabidiol (CBD) Patent, IP and TechnologyBy Nasdaq OMXFeb 6, 2017, 12:45 PM UTC
BusinessHemispherx Biopharma Announces Extension of Rintatolimod European Early Access Program (EAP) to Pancreatic Cancer PatientsBy Nasdaq OMXJan 11, 2017, 1:31 PM UTC
